Med. praxi. 2010;7(12):485-488
Multiple sclerosis (MS) is a serious neurological disorder leading without treatment to irreversible disability. Diagnostic process may
be rapid enough if the symptoms are not underestimated and MS is considered. Both early start of immunomodulatory treatment and
early administration of methylprednisolon in case of acute attack reduce tissue damage in MS. Patient´s quality of life depends also on
adverse events prevention and symptomatic treatment.
Published: January 1, 2011 Show citation